Transfusion-Dependent Beta Thalassemia

The Transfusion-Dependent Beta Thalassemia pipeline: 3 tracked drugs, 2 approved for this indication.

Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Transfusion-Dependent Beta Thalassemia, so this list is not complete.

2 approved / phase 41 Phase 3

Compare the share prices of listed companies in Transfusion-Dependent Beta Thalassemia →

Market size not yet sourced. How markets are sized ↗

The Transfusion-Dependent Beta Thalassemia pipeline

← all assets